In 2023, the share of corresponding/leading authors in scientific publications in drug discovery in Germany was not provided. However, the forecast from 2024 indicates a gradual decrease from 87.22% in 2024 to 87.05% in 2028, revealing a subtle declining trend. The year-on-year reduction is consistent, illustrating a minor decrease each year. This results in a negative compounded annual growth rate over the five-year forecast period.

Future trends might include:

Potential shifts in collaborative research practices, inclining towards more co-authorship dynamics.
Impact of increasing international collaborations on authorship shares.
Technological advancements could potentially alter the landscape of author contributions and recognition.